Haemonetics (HAE) Total Non-Current Liabilities (2010 - 2026)
Haemonetics (HAE) posted quarterly Total Non-Current Liabilities of $2.3 billion for Q1 2026, down 1.94% year-over-year from $2.4 billion in Q1 2025, and down 3.74% quarter-over-quarter from $2.4 billion in Q4 2025.
Haemonetics (HAE) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Haemonetics' Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $2.3 billion for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 1.94% year-over-year to $2.3 billion; the TTM figure through Mar 2026 stood at $2.3 billion (down 1.94% YoY), while the FY2026 annual figure was $2.3 billion, down 1.94% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $2.3 billion, down from $2.4 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $2.4 billion in Q2 2024, with the low at $1.7 billion in Q1 2022.
- The 5-year median for Total Non-Current Liabilities is $2.1 billion (2023), against an average of $2.1 billion.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities surged 43.53% in 2022, then fell 2.43% in 2025.
- Haemonetics' Total Non-Current Liabilities stood at $1.8 billion in 2022, then advanced by 18.02% to $2.1 billion in 2023, then increased by 14.93% to $2.4 billion in 2024, then decreased by 0.57% to $2.4 billion in 2025, then fell by 3.74% to $2.3 billion in 2026.
- Business Quant data shows HAE's Total Non-Current Liabilities at $2.3 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn | 2.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 2.31 Bn |
| Mar 28, 2026 | 2.34 Bn |
| Dec 27, 2025 | 2.43 Bn |
| Sep 27, 2025 | 2.38 Bn |
| Jun 28, 2025 | 2.39 Bn |
| Mar 29, 2025 | 2.38 Bn |
| Dec 28, 2024 | 2.44 Bn |
| Sep 28, 2024 | 2.44 Bn |
| Jun 29, 2024 | 2.45 Bn |
| Mar 30, 2024 | 2.12 Bn |
| Dec 30, 2023 | 2.12 Bn |
| Sep 30, 2023 | 1.94 Bn |
| Jul 1, 2023 | 1.89 Bn |
| Apr 1, 2023 | 1.86 Bn |
| Dec 31, 2022 | 1.80 Bn |
| Oct 1, 2022 | 1.79 Bn |
| Jul 2, 2022 | 1.75 Bn |
| Apr 2, 2022 | 1.78 Bn |
| Jan 1, 2022 | 1.75 Bn |
| Oct 2, 2021 | 1.71 Bn |